If the interventional glaucoma trend continues to grow in popularity though, and more doctors continue to make the shift from stents and toward canaloplasty, I definitely think the canal surgery market will be far larger than just $450 million. The total glaucoma treatment market is over $6 billion and cataract surgery is around $10 billion, so it shouldn't be hard to penetrate even a small percentage of those markets and significantly boost the total market for canal surgery. The cool thing as well about canal surgery is that it is a very nice complement to nearly every other procedure (eg cataracts, stents etc) as many doctors seem to like the idea of cleaning out the canal before stenting or doing another type of procedure.
- Forums
- ASX - By Stock
- Nova Eye Medical (EYE) Discussion
If the interventional glaucoma trend continues to grow in...
-
-
- There are more pages in this discussion • 1,037 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
21.5¢ |
Change
-0.005(2.27%) |
Mkt cap ! $49.19M |
Open | High | Low | Value | Volume |
22.0¢ | 22.5¢ | 21.5¢ | $130.0K | 589.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 506631 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 9070 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 506631 | 0.215 |
5 | 149761 | 0.210 |
2 | 29540 | 0.205 |
11 | 131320 | 0.200 |
2 | 8000 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 9070 | 1 |
0.230 | 67523 | 3 |
0.235 | 15000 | 1 |
0.240 | 28253 | 1 |
0.245 | 26000 | 2 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online